New Sensor Chip Shows Promise for Rapid, Low-Cost POC Disease Diagnostics
|
By LabMedica International staff writers Posted on 27 Jun 2023 |

The Loop-Mediated Isothermal Amplification (LAMP) technique is a popular method for identifying pathogens by amplifying their DNA. The detection of LAMP-amplified products, such as the DNA of pathogens, typically requires the use of fluorescent dyes to "label" these products, which can be expensive and have low sensitivity. Now, researchers have designed a new sensor capable of diagnosing pathogens without the need for these reagents and with a high degree of sensitivity. This new development also eliminates the time-consuming process of DNA purification, which often poses challenges for point-of-care applications.
Scientists at Texas A&M AgriLife Research (College Station, TX, USA) in collaboration with Iowa State University (Ames, IA, USA) have developed a sensor chip capable of identifying numerous disease-causing pathogens with ten times the sensitivity of existing techniques. The sensor chip eliminates the need for chemical dye reagents typically employed in diagnostics. The innovative chip consists of a nanopore thin-film sensor housed within a unique reaction chamber. Uniquely designed primers are immobilized on the nanofilm, causing the amplified LAMP products to bind to the sensor. The resulting signals can then be directly and easily measured using a portable spectrometer. The sensor delivers results within approximately 30 minutes. This new technology holds the promise of rapid, inexpensive point-of-care diagnostics in various sectors, including plants, food, animals, and human health, including the detection of foodborne pathogens, bird flu, and COVID-19.
In their study, the researchers used the innovative sensor to identify Phytophthora infestans, a pathogen that causes the highly destructive late blight disease, posing a significant threat to potato and tomato crops worldwide. The LAMP chip offers a new portable platform for pathogen detection, employing label-free sensors with exceptional sensitivity. The research team will now focus on increasing its sensitivity to the subattomolar levels or even lower. They aim to overcome the existing challenges in identifying and differentiating pathogen species and strains that share high sequence similarities. The team also plans to improve detection specificity and implement quantitative detection by integrating artificial intelligence and CRISPR gene-editing technologies. Their goal is to develop a feasible product for wide-ranging use in plant, animal, and human health point-of-care applications.
“This research advances technologies that have emerged as some of our greatest opportunities for improving agriculture, food safety and human health,” said Junqi Song, Ph.D., associate professor and plant immunity research lead with AgriLife Research. “Our publication represents a step toward realizing these powerful tools against diseases.”
Related Links:
Texas A&M AgriLife Research
Iowa State University
Latest Technology News
- Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
- Autonomous Robotic System Receives FDA Authorization for Blood Collection
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
Channels
Clinical Chemistry
view channel
New Blood Biomarker Predicts May Predict Preeclampsia and Fetal Growth Restriction
Preeclampsia and fetal growth restriction are major drivers of stillbirth and serious maternal morbidity, yet clinicians still lack reliable early predictors to guide targeted surveillance.... Read more
Biomarker Score Helps Differentiate Takotsubo Syndrome from Myocardial Infarction
Takotsubo syndrome, often called broken-heart syndrome, mimics myocardial infarction and can be difficult to triage in emergency settings. It accounts for about 2% of suspected heart attacks and up to... Read moreHematology
view channel
New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome
Inherited bone marrow failure syndromes (IBMFS) impair the bone marrow’s ability to produce sufficient healthy blood cells and are associated with an increased risk of early-onset myelodysplastic syndromes (MDS).... Read more
Ultra-Portable Device Enables Finger-Prick Blood Testing at Home
Patients who need frequent blood tests often face repeated clinic visits that burden services and disrupt care. In the UK, millions of tests are performed each year to diagnose disease, guide therapy,... Read moreImmunology
view channel
New Cellular Map May Help Predict Crohn’s Disease Course in Children
Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more
Temporal Immune Profiling Reveals How Sepsis States Change Over Time
Sepsis is a life-threatening condition in which the immune response to infection becomes dysregulated, leading to rapid organ failure and death. Although antimicrobials and organ support remain standard... Read more
Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19
Autoantibodies that mistakenly attack the body’s own tissues have been linked to severe COVID-19, Long COVID, and increased risk of autoimmune disease. However, the origins of these autoantibodies during... Read moreMicrobiology
view channel
Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification
Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours
Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read morePathology
view channel
Label-Free Imaging Reveals Hidden Immune Activity in Blood Samples
Peripheral blood mononuclear cells (PBMCs) are widely used to monitor infection, autoimmunity, cancer, and treatment response, yet most assays depend on fluorescent labels that can perturb cells and provide... Read more
AI Tool Improves Prediction of Immunotherapy Response in Lung Cancer
Immune checkpoint therapies benefit only a subset of patients, while standard biomarkers often struggle to predict who will respond. Spatially resolved tumor profiling can provide deeper biological context,... Read moreTechnology
view channel
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
Recombinant proteins are central to many cancer diagnostics and therapies, but numerous targets remain difficult and costly to produce because they are unstable, toxic to microbial hosts, or require precise folding.... Read more
Autonomous Robotic System Receives FDA Authorization for Blood Collection
Venipuncture is central to many diagnostic pathways, but routine blood collection can be affected by staffing constraints and procedural variability that influence consistency and patient experience.... Read moreIndustry
view channel
New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
Rapid and accurate classification of central nervous system tumors remains a challenge, particularly in children where histology alone can misclassify aggressiveness and drive overtreatment.... Read more







